Delivery Order HHSN261201600016I-HHSN26100001

This is a Cost Plus Fixed Fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The contract is for an exploratory toxicology study in dogs of an MCL-1 inhibitor drug being developed for cancer and other diseases. The contract has a potential value of $116,039 and a completion date of June 30, 2021. It is a task...

This is a delivery order worth $3,102 awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute, a nonprofit research and development organization, for a contract orientation meeting related to preclinical pharmacology and toxicology studies. The delivery order was issued under a larger Preclinical Pharmacology and Toxicology Studies contract vehicle that runs from 2012 to 2014. The award does not have a set-aside designation. Battelle frequently partners with universities...

This is a delivery order under the Toxicology of Drugs Developed for Cancer Patients contract vehicle, awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute. The $248,269.21 cost-plus-fixed-fee contract is for a pre-clinical toxicity study to characterize the toxicity of potential anticancer compounds following multiple dose administration to rats. The contract runs from January 18, 2017 to June 30, 2018. No set-aside designation is mentioned. Battelle frequently serves...

This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract is valued at $761,043.02 and is part of the larger "Toxicology of Drugs Developed for Cancer Patients" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The purpose of this award is to conduct pre-clinical toxicology studies of a drug candidate, specifically DNA methyltransferase-TdCyd, for potential use in...

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...

<p>This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency, to Biosimulation Consulting Inc. for toxicological and toxicokinetic studies of xenobiotics. The contract has a ceiling value of $75,000.00 and a completion date of June 12, 2017. The contract was not set aside for any specific business type. The National Cancer Institute is responsible for the funding of this contract.</p>

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...

This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to IIT Research Institute, a non-profit research organization, for a series of toxicology studies in rabbits for drugs developed for cancer patients. The $487,537.00 contract is part of the Toxicology of Drugs Developed for Cancer Patients indefinite delivery/indefinite quantity contract vehicle and includes dose range finding, preliminary embryo fetal...